The hurricane Melissa’s passage over Holguín left the environmental conditions deteriorated and the epidemiological situation worsened. Many people are experiencing joint pain, fever, loss of appetite, restricted mobility, and general discomfort. The “virus” is present in several areas of the locality, increasing concerns for health authorities.
Cuban health authorities have begun a clinical trial of the drug Jusvinza, developed by the Center for Genetic Engineering and Biotechnology, to treat residual polyarthritis in patients recovering from Chikungunya, the Biocubafarma Group announced on its Facebook profile.
There is no shortage of solidarity for the first hospital inaugurated by the Revolution in eastern Cuba. This time, Chilean Miguel Sanhuesa, who lives in Canada, arrived in the city of Holguín with supplies and ozone therapy equipment.
Holguín will hold the 2025 Traveling Congress on October 27 and 28, aimed at contributing to the improvement of the specialty of surgery with a multidisciplinary approach.